AU Patent

AU2002364935A1 — Enhancement of immune responses by 4-1bb-binding agents

Assigned to Mayo Clinic in Florida · Expires 2003-06-23 · 23y expired

What this patent protects

This invention features methods of enhancing immune responses in mammalian subjects and in vitro methods of enhancing the response of a T cell. Also embodied by the invention are methods of receiving and preventing the induction of energy in T cells.

USPTO Abstract

This invention features methods of enhancing immune responses in mammalian subjects and in vitro methods of enhancing the response of a T cell. Also embodied by the invention are methods of receiving and preventing the induction of energy in T cells.

Drugs covered by this patent

Patent Metadata

Patent number
AU2002364935A1
Jurisdiction
AU
Classification
—
Expires
2003-06-23
Drug substance claim
No
Drug product claim
No
Assignee
Mayo Clinic in Florida
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.